Portuguese Version

Year:  2000  Vol. 66   Ed. 3 - ()

Artigos Originais

Pages: 200 to 205

Early Glottic Cancer - Outcome in the Treatment of T1 Glottic Carcinoma.

Author(s): Agrício N. Crespo*,
Rebecca C. K. Maunsuell**,
Rogério M. Oliveira***.

Keywords: larynx, carcinoma, glottis, surgery, radiotherapy

Introduction: T1 glottic carcinoma treatment remains a matter of discussion. When making a choice between radiotherapy and surgery one must consider aspects of the tumor, the patient, treatment cost and complications and patients choice. Aim: Our purpose is to review the outcome of 40 patients with T1 glottic carcinoma treated at the Department of Otolaryngology of the Medical School of the University of Campinas (UNICAMP) from 1989 through 1997. Results: We analyzed retrospectively records of patients with T1 glottic carcinoma treated and followed by the Head and Neck Surgery Section of the Department of Otolaryngology at the State University of Campinas. We found 36 men and four women. The tumor was unilateral in 72,5% and bilateral in 27,5%. Extension to the anterior commissure was present in 40%. Recurrence occurred in three patients. The complications were sinequia, granulomas, edema and dysphagia. Conclusion: From the analysis of these 40 cases of T1 glottic carcinoma we conclude: l) Primary or salvage surgery presented 100% tumor control. 2) Radiotherapy is highly effective and had 85% tumor control rate. 3) Clinical extension to the anterior commissure had no relation with recurrence. 4) The occurrence of complications was comparable although proved to be of different nature for each treatment. 5) Bilateral tumor were mostly treated with radiotherapy. 6) In the sane stage, tumor extension influenced the choice between surgery and radiotherapy. 7) The choice between surgery and radiotherapy must consider the surgeon's experience and the qualification of the radiotherapy service, and also characteristics of the tumor and the patient's decision.






Voltar Back      Topo Top


All rights reserved - 1933 / 2024 © - Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico Facial